Log in or Sign up for Free to view tailored content for your specialty!
Glaucoma News
IOP decrease maintained with Xen45
SAN FRANCISCO — Decrease in IOP as well as medication burden was sustained over a 12-month period in eyes implanted with the Xen45 gel stent, according to a poster presented at the American Glaucoma Society annual meeting.
Treatment may not be necessary in children with intermittent exotropia
Children 3 to 10 years old with intermittent exotropia are not likely to progress to constant exotropia and may improve spontaneously over 3 years, according to a study.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Zeiss expands diagnostics portfolio
NEW YORK – Carl Zeiss Meditec’s Angelo Rago said the company is introducing products here at Vision Expo East, “that bring patients to your office.”
Prophylactic laser peripheral iridotomy may be overused
SAN FRANCISCO — As a prophylactic measure in patients labeled primary angle-closure suspects, laser peripheral iridotomy may be overused, a speaker said.
Dysphotopsias after LPI tend to resolve
SAN FRANCISCO — Most patients who report new dysphotopsias after laser peripheral iridotomy for primary angle-closure glaucoma can be reassured that these manifestations are likely to resolve, Nazlee Zebardast, MD, told colleagues at the American Glaucoma Society meeting.
New drug delivery technologies may improve compliance in glaucoma patients
NEW ORLEANS – New drug delivery technologies will assist clinicians in treating noncompliant glaucoma patients, Ike K. Ahmed, MD, said here at SECO.
Hydrus reduces medication burden in COMPARE trial
SAN FRANCISCO — Medication burden was significantly reduced more in glaucomatous eyes implanted with the Hydrus device vs. two iStent devices at 2 years postoperatively, according to COMPARE trial results presented here.
iStent inject reduces IOP relative to starting pressure
SAN FRANCISCO — Decrease in IOP attributable to phacoemulsification “maxes out” regardless of starting baseline pressure, whereas the effect of the iStent inject continues to increase with increasing baseline pressure, Inder Paul Singh, MD, told Healio.com/OSN at the American Glaucoma Society annual meeting.
Kahook Dual Blade reduces IOP with and without phaco
SAN FRANCISCO — The Kahook Dual Blade procedure, with or without phacoemulsification, reduced IOP at 18 months, even more so in eyes with pseudoexfoliation, according to a poster presented here.
Long-term IOP control maintained with tube surgery in uveitic eyes
SAN FRANCISCO — Glaucoma drainage implants maintain long-term control of IOP in uveitic eyes with fluocinolone acetonide implants, according to a poster presented at the American Glaucoma Society annual meeting.
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read